You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Vicore begins vital endothelial dysfunction study

Vicore Pharma has announced that the first patient has been dosed with its C21 candidate during a pivotal clinical study of endothelial dysfunction.